Search

Search Constraints

You searched for: Author/Creator Bronowicki, Jean‐Pierre

Search Results

1. 25‐OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV‐infected patients. Issue 1 (1st February 2017)

2. ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts. (17th January 2022)

3. Accuracy of calprotectin using the Quantum Blue Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis. Issue 1 (4th September 2018)

4. An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study). Issue 1 (5th December 2022)

5. Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial. Issue 3 (11th February 2013)

6. Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial1234. Issue 3 (11th February 2013)

7. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). Issue 3 (20th March 2015)

8. Corrigendum. Issue 10 (26th October 2021)

9. Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme. (8th March 2017)

10. Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+). Issue 5 (4th March 2016)